Physical activity in the prevention of chronic diseases of academic students
DOI:
https://doi.org/10.12923/j.0044-2011/123-1/a.13Keywords:
students , cardiovascular diseases, diabetes, metabolic syndrome, physical activityAbstract
Academic studies cover usually a period of life between 19 and 25 years of age. It is the time of transition from living in the family home under the care of parents to becoming an independent adult. New habits developed in this period are often extrapolated to improper nutritional attitudes and inappropriate patterns of behavior that may result in health deterioration among graduates in their future lives.
The meta-analysis has revealed that an unfavorable health condition of the Polish population is connected with a high incidence of chronic diseases. It calls for immediate actions aimed at identifying factors that contribute to an increasing incidence of diseases. It is justified to diagnose this phenomenon among university students burdened with such risk factors as arterial hypertension, dyslipidemia, impaired glucose tolerance or low physical activity.
The population of 20-34-year-olds has low awareness of the non-pharmacological methods of preventing chronic diseases, as indicated by multicenter national studies WOBASZ and NATPOL-PLUS on health population.
Health benefits of physical activity are more and more recognized and appreciated. Physical exertion influences blood pressure, improves lipid parameters, decreases insulin resistance, helps to maintain proper body mass, and improves general physical and mental state. The influence of physical exertion on the body is indisputable. Therefore, it is necessary to pay more attention to everyday spontaneous physical activity especially during studies.
References
1. Duda G, Suliburska J. Stosowanie używek i ocena wybranych para¬metrów stanu zdrowia młodzieży akademickiej. Now Lek. 2002;78(4-5):217-21.
2. Wołos J, Tarach JS, Klatka M. Występowanie otyłości i środowiskowych czynników ryzyka miażdżycy w grupie studentów uczelni z Lublina. Endokrynol Otyłość Zaburz Przem Mat. 2009;5(2):66-72.
3. Poręba R, Gaś P, Zawadzki M, et al. Styl życia i czynniki ryzyka chorób układu krążenia wśród studentów uczelni Wrocławia. Pol Arch Med Wewn. 2008;118(3):102-10.
4. Charkiewicz WJ, Markiewicz R, Borowska MH. Ocena sposobu żywienia studentek dietetyki Uniwersytetu Medycznego w Białymstoku. Bromat Chem Toksykol. 2009;42(3):699-703.
5. Harton A, Myszkowska-Ryciak J. Ocena sposobu żywienia studentek Szkoły Głównej Gospodarstwa Wiejskiego w Warszawie. Bromat Chem Toksykol. 2009;42(3):610-4.
6. Ilow R. Ocena sposobu żywienia wybranych grup populacji dolnośląskiej – studenci. Żyw Człow Metab. 2007;34(1/2):653-8.
7. Marzec Z, Koch W, Marzec A. Ocena wartości energetycznej oraz po¬brania wybranych biopierwiastków i witaminy C z całodziennymi dieta¬mi studentów. Bromat Chem Toksykol. 2008; 41(3): 433-7.
8. Czeczelewski J, Skład M, Saczuk J, Raczyński G. Relationships be¬tween feeding manner, somatic features and physical fitness in children at adolescence. Biol Sport. 2001;18(2):147-59.
9. Raczyński G, Czeczelewski J, Skład M, Stupnicki R. Interrelationships among food intake, somatic traits, and physical fitness in 10.5-15.5 year-old children from Eastern Poland. Int J Sport Nutr. 1998;8(4):388-400.67 Zdr Publ 2013;123(1)
10. Waśkiewicz A. Jakość żywienia i poziom wiedzy zdrowotnej u młodych dorosłych Polaków – badania WOBASZ. Probl Hig Epidemiol. 2010;91(2):233-7.
11. Zdojewski T, Bandosz P, Szpakowski P, et al. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL-PLUS. Kardiol Pol. 2004;61(suppl. IV):IV1-IV26.
12. Wysoki MJ, Zejda JE. Epidemiologia chorób niezakaźnych w Polsce w drugiej połowie dwudziestego wieku. Przegl Epidemiol. 2007; 61(4):615-28.
13. Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO metabolic syndrome in European cohorts, and alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28(5):365-76.
14. McGill HC, McMahan CA. Starting earlier to prevent heart disease. JAMA. 2003;290(17):2320-2.
15. Berenson GS, Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. Am J Cardiol. 2002;90(10C):3L-7L.
16. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood. JAMA. 2003;290(17):2271-6.
17. Cruz ML, Goran MI. The metabolic syndrome in children and adoles¬cents. Curr Diab Rep. 2004;4(1):53-62.
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-9
19. Meigs JB, Wilson PW, Nathon DM, et al. Prevalence and characteristic of metabolic syndrome in the San Antonio Heart and Framingham Off¬spring Studies. Diabetes. 2003;52(8):2160-7.
20. Misra A. Risk factors for atherosclerosis in young individuals. J Cardio¬vasc Risk. 2000;7(3):215-29.
21. Lewington S, Clarke R, Oizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of in¬dividual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-13.
22. Zdrojewski T. Nadciśnienie tętnicze w Polsce. Terapia. 2002;124(7/8):4-7.
23. Kobus G, Łagoda K, Bachórzewska-Gajewska H. Niefarmakologiczne metody leczenia dzieci i młodych osób chorych na nadciśnienie tętnicze. Endokrynol Otyłość Zaburzenia Przem Mat. 2008;4(4):163-7.
24. Widecka K. Nadciśnienie tętnicze u dzieci i młodzieży – coraz większy problem medyczny. Choroby Serca Naczyń. 2004;1(2):89-96.
25. Krzych Ł, Kowalska M, Zejda JE. Styl życia młodych dorosłych osób z podwyższonymi wartościami ciśnienia tętniczego. Nadciśnienie Tętnicze. 2006;10(6):524-31.
26. Kemper HCG. Growth, health and fitness of teenagers. Longitudinal research in international perspective. Medicine and Sport Science. New York, NY, USA: Karger; 1985.
27. Deckelbaum RJ, Fisher A, Winston M, et al. Summary of a Scientific Conference on Preventive Nutrition: Pediatrics to Geriatrics. Circula¬tion. 1999;100(4):450-6.
28. Cybulska B, Adamus J, Bejnarowicz J. Profilaktyka choroby niedokr¬wiennej serca – rekomendacje Komisji Profilaktyki PTK. Kardiol Pol. 2000;53(suppl. I):5-45.
29. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hyperten¬sion (DASH) diet. N Eng J. 2001;344(1):3-10.
30. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern. 2001;135(12):1019-28.
31. Nowakowski A. Epidemiologia cukrzycy. Diabet Prakt. 2002;3(4):181-5.
32. Jarosz-Chobot P, Otto-Buczkowska E. Epidemiologia cukrzycy typu 1. Przegl Pediatr. 2009;39(4):229-34.
33. Patterson CC, Dahlquist GG, Gyürüs E, et al. EURODIAB Study Group: Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-2020: a multicentre prospec¬tive registration study. Lancet. 2009;373(9680):2027-33.
34. Jarosz-Chobot P, Polańska J, Szadkowska A, et al. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetol. 2011;54:508-15.
35. Szybiński Z. Polish Multicenter Study on Diabetes Epidemiology (PMSDE) – 1998-2000. Pol Arch Med Wewn. 2001;106(3):751-8.
36. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
37. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21(4):518-24.
38. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type diabetes 2 in youth. Diabetes Care. 1999;22(2):345-54.
39. Fajans SS, Maturity-onset diabetes of the young (MODY). Diabetes Me¬tab Rev. 1989;5(7):579-606.
40. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Ed. 2001;344(18):1343-50.
41. Eriksson KF, Lindgärde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasi¬bility study. Diabetol. 1991;34(12):891-8.
42. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-44.
43. Lindström J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230-6.
44. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the inci¬dence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
45. Trepińska M, Zozulińska D, Araszkiewicz A, Wierusz-Wysocka B. Ocena samokontroli glikemii u chorych na cukrzycę typu 1 leczonych metodą intensywnej insulinoterapii. Diabetol Prakt. 2002;3(2):69-73.
46. Piłaciński S, Czyż K, Malida J, et al. Ocena wiedzy o cukrzycy wśród studentów V i VI roku Wydziału Lekarskiego. Now Lek. 2003;72(1):37-41.
47. Raczyńska B, Zubik Ł, Jeliński M. Cukrzyca a wysiłek fizyczny. Pol J Sport Tourism. 2011;18(1):10-6.
48. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607.
49. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the meta¬bolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.
50. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: preva¬lence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351-75.
51. Wyrzykowski B, Zdrojewski T, Sygnowska E, et al. Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. Kardiol Pol. 2005;63(6):S1-S4.
52. Sung RY, Tong PC, Yu CW, et al. High prevalence of insulin resistance and metabolic syndrome in overweight/ obese preadolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care. 2003;26(1):250-1.
53. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syn¬drome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7.
54. Freedman DS, Dietz WH, et al. The relation of overweight to cardiovas¬cular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics. 1999;103(6):1175-82.
55. Franks PW, Hanson RL, Knowler WC, et al. Childhood obesity, other cardiovascular risk factor and premature death. N Eng J Med. 2010;362(6):485-93
56. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and car¬diovascular risk a systematic review and meta-analysis. J Am Coll Kar¬diol. 2010;56(14):1113-32.
57. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circ. 2005;112(5):666-73.
58. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-9.
59. Sattar N, Gaw G, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circu¬lation. 2003;108(4):414-9.68 Zdr Publ 2013;123(1)
60. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syn¬drome and its relation to all-causes and cardiovascular mortality in non¬diabetic European men and women. Arch Intern. 2004;164(10):1066-76.
61. Paffenbarger RS, Hale WE. Work activity and coronary heart mortality. N Engl J Med. 1975;292:545-50.
62. Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314(10):605-13.
63. Morris JN, Heady JA, Raffle PAB, et al. Coronary heart disease and physical activity of work. Lancet. 1953;265(6796):1111-20.
64. Kahn HA. The relationship of reported coronary heart disease mortality to physical activity of work. Am J Public Health. 1963;53:1053-63.
65. Blair SN, Kampert JB, Kohl WH, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996;276(3):205-10.
66. Kelley GA, Kelley KA, Tran ZV. Aerobic exercise and resting blood pressure: A meta-analytic review of randomized controlled trials. Prev Kardiol. 2001;4(2):73-80.
67. Lee IM, Skerret PJ. Physical activity and all-cause mortality: what is the dose-response relation? Med Sci Sport Exerc. 2001;33(6):459-71.
68. Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. CMAJ. 2006;174(6):801-9.
69. Leon AS, Myers MJ, Connett J. Leisure time physical activity and the 16-year risk of mortality from coronary heart disease and all-cause in the Multiple Risk Factor Intervention Trial (MRFIF). Int J Sports. 1997;18(suppl.3):S208-S215.
70. Ishikawa-Takada K, Ohta T, Tanaka H. How much exercise is required to reduce blood pressure in essential hypertensives: A dose – response study. Am J Hypertens. 2003;16(8):629-33.
71. Lee IM, Rexrode KM, Cook NR, et al. Physical activity and coronary heart disease in women. JAMA. 2001;285(11):1447-54.
72. Morrato EH, Hill JO, Wyatt HR, et al. Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care. 2007;30(2):203-9.
73. Sigal RJ, Kenny GP, Wasserman DH, et al. Physical activity/exercise and type 2 diabetes. Diabetes Care. 2006;29(6):1433-8.
74. Colberg SR, Swaln DP. Exercise and diabetes control. Physic Sports med. 2000;28(4):63-7.
75. Despres JP, Pouliot MC, Moorjani S, et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol Endocrinol Metab. 1991;261(2):E159-E167.
76. Ekelund U, Franks P. Sharp S. et al. Increase in physical activity energy expenditure in associated with reduced metabolic risk indepen-dent of change in fatness and fitness. Diabetes Care. 2007;30(8):2101-6.
77. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347(19):1483-92.
78. Janssen I, Fortier A, Hudson R, Ross R. Effects of an energy-restric¬tive diet with or with-out exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care. 2002;25(3):431-8.
79. Rice B, Janssen I, Hudson R, Ross R. Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care. 1999;22(5):684-91.
80. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J. 1991;325:461-6.
81. Bouchard C, Shephard RJ. Physical activity, fitness, and health: The model and key concepts. In: C. Bouchard, RJ Shephard, T. Stephens (ed). Physical activity, fitness, and health. International proceedings and consensus statement. Human Kinetics Champaingn; 1994. p. 77-88.
